European Medicines Agency
AstraZeneca: ‘No evidence’ of higher blood clots risk from coronavirus vaccine
UK-based pharmaceutical company AstraZeneca insisted on Friday its coronavirus vaccine was safe after some countries suspended its use in response to concerns about a potential link to blood clots. “An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any defined age group, gender, batch or in any particular country” from the jab, a company spokesperson said. “In fact, the observed number of these types of events are significantly lower in those vaccinated than would be expected among the general population.” The AstraZeneca jab, developed with Oxford University, forms the mainstay of Britain’s vaccination programme, and of many developing economies. It is relatively cheap and easier to st...
Germany starts coronavirus vaccines a day early
A 101-year-old woman in an elderly care home became the first person in Germany to be inoculated against coronavirus on Saturday, a day before the official vaccination campaign was scheduled to get under way in both Germany and the EU. Edith Kwoizalla was one of around 40 residents and 10 staff in a care home in the eastern state of Saxony-Anhalt to receive a jab of the Pfizer-BioNTech vaccine, the home’s manager Tobias Krueger told AFP. The Pfizer-BioNTech vaccine became the first to get the go-ahead for use in the West, when Britain gave its approval on December 2. As other nations from the United States to Saudi Arabia to Singapore followed suit, Germany impatiently prodded the EU’s drugs regulator, the European Medicines Agency, to bring forward its decision from December 29. The EMA f...
France: Coronavirus vaccine will be free for all
France will ensure free COVID-19 vaccinations for all who are in its social security system and has earmarked 1.5 billion euros of next year’s social security budget to cover the cost, Prime Minister Jean Castex said on Thursday. Castex said the vaccination campaign would begin in a matter of weeks, pending regulatory approval by the European Medicines Agency. The inoculation programme would be staggered over three categories of people, he said, commencing with the most vulnerable in nursing homes. “The vaccination will be free for all,” Castex told a press conference. France has ordered some 200 million doses from different pharmaceutical companies developing vaccines, Castex said, enough to inoculate 100 million people – more than France’s population. The COVID-19 vaccination will be vol...
EU criticises ‘hasty’ UK approval of coronavirus vaccine
The European Union criticised Britain’s rapid approval of Pfizer and BioNTech’s COVID-19 vaccine on Wednesday, saying its own procedure was more thorough, after Britain became the first western country to endorse a COVID-19 shot. The move to grant emergency authorisation to the Pfizer/BioNTech vaccine has been seen by many as a political coup for UK Prime Minister Boris Johnson, who has led his country out of the EU and faced criticism for his handling of the pandemic. The decision was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only ten days after it began examining data from large-scale trials. In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving COVID...
